BlackRock Fund Advisors’s Perspective Therapeutics CATX Stock Holding History

BlackRock Fund Advisors’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Buy	1,649 +378	+30%	+$2.31K	﹤0.01%	3959
2016 Q3	$9K	Sell	1,271 -9,239	-88%	-$70.4K	﹤0.01%	3974
2016 Q2	$91K	Sell	10,510 -3,315	-24%	-$31.7K	﹤0.01%	3692
2016 Q1	$124K	Sell	13,825 -1,051	-7%	-$8.28K	﹤0.01%	3605
2015 Q4	$139K	Buy	14,876 +665	+5%	+$8.28K	﹤0.01%	3647
2015 Q3	$199K	Sell	14,211 -376	-3%	-$5.43K	﹤0.01%	3464
2015 Q2	$216K	Sell	14,587 -304	-2%	-$4.93K	﹤0.01%	3499
2015 Q1	$234K	Sell	14,891 -1,009	-6%	-$15K	﹤0.01%	3443
2014 Q4	$232K	Buy	15,900 +1,136	+8%	+$18K	﹤0.01%	3442
2014 Q3	$250K	Buy	14,764 +482	+3%	+$11.9K	﹤0.01%	3396
2014 Q2	$446K	Buy	+14,282	New	+$358K	﹤0.01%	3222

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock Fund Advisors's CATX Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Perspective Therapeutics (CATX) stake by 30% in Q4 2016, buying an estimated $2.31K and bringing the position to 1,649 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #3959.

BlackRock Fund Advisors first reported a position in CATX in Q2 2014 and has held it in 11 quarters since. The position peaked at $446K in Q2 2014. 30 funds tracked by Wall St. Rank hold CATX as of Q4 2016.

BlackRock Fund Advisors held 1,649 shares of Perspective Therapeutics worth $10K as of Q4 2016.
BlackRock Fund Advisors bought 378 Perspective Therapeutics shares in Q4 2016, an estimated $2.31K.
Perspective Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3959 holding.
BlackRock Fund Advisors first reported a position in Perspective Therapeutics in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Perspective Therapeutics position peaked at $446K in Q2 2014.
30 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.